The concurrent use of chemotherapy showed a trend of better prognosis, although the difference was not statistically significant (p = 0.062).
← all excerpts
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study.
1
—
—